QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs
SARS-CoV-2에 감염되어 항바이러스제 치료를 받은 환자의 QTc 간격 연장
Article
[키워드] adverse effect
affected
analyzed
Antiviral
Antiviral agents
antiviral drug
antiviral therapy
arrhythmia
Azithromycin
Azitromicin
Azitromicina
basal
baseline
caused
Child
congenital heart disease
Control
COVID-19
disease
electrocardiogram
Electrocardiograma
Electrocardiograms
Electrocardiography
English
event
heart disease
Hidroxicloroquina
hubo
Hydroxychloroquine
Immunosuppression
increase in
infected with SARS-CoV-2
Long
Long QT syndrome
Lopinavir
Lopinavir/ritonavir
median
no difference
no differences
paediatric patients
Patient
patients
Pediatría
pediatrics
QT largo
QTc
QTc interval
QTC prolongation
Remdesivir
resulting
Ritonavir
SARS-CoV-2
SARS-CoV-2.
Spanish
treat
treated
Treatment
underlying diseases
use of hydroxychloroquine
ventricular
[DOI] 10.1016/j.anpede.2021.04.006 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.anpede.2021.04.006 PMC 바로가기 [Article Type] Article